Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $98.5000 (-2.62%) ($97.2000 - $100.2000) on Tue. Feb. 2, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 52 | Latest Price | $98.5000(-2.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.34% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $99 | 5 Day Moving Average | $99.4(-0.91%) | 10 Day Moving Average | $100.24(-1.74%) | 20 Day Moving Average | $99(-0.51%) | To recent high | -11.9% | To recent low | 5.5% | Market Cap | $1.583b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |